UNSPSC 51422370: Flumetasone or flumethasone

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H28F2O5, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier LR3CD8SX89, chemically known as 6,9-difluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione but more generally known as flumetasone, which bears U.S. NIH Compound Identifier 16490. European Medicines Agency schedules Flumetasone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07698MIG.

UNSPSC 51422370 Flumetasone or flumethasone is a Commodity code that, based on recent state and local activity, does not align with what is actually being solicited under it. The two most recent opportunities tagged to this code—one for naloxone and drug deactivation systems and one for direct-to-manufacturer pharmacy benefit management—bear no relationship to flumetasone, a topical corticosteroid medication. The code shows little relevant recent activity; the opportunities on record appear to reflect data entry or taxonomy-assignment errors rather than genuine procurement of flumetasone products by state or local agencies.

No actionable recent opportunities for flumetasone procurement are present in the source material. Business development professionals should not pursue this code based on current posting activity and should monitor whether future opportunities correctly reflect the actual scope of pharmaceutical or medical goods being purchased.